The exclusive License Agreement grants NLS Pharmaceutics global rights to next-generation non-sulfonamide orexin-1 / orexin-2 receptor agonists, tailored to target…
GOTHENBURG, SE / ACCESSWIRE / March 19, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, 19 March 2024 - IRLAB Therapeutics…
The Care Alliance agreement features a systematic approach focused on innovation, patient and staff experience, and imaging advancements through 2030HARTFORD,…
WATERTOWN, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug…
The Princess Royal was introduced to the first FDA-cleared portable MR brain imaging system being used to test the disparities…
Provides update on two late-stage clinical programs for BXCL501 for potential treatment of agitation Recently completed meetings with U.S. Food…
BENTON, Ark.--(BUSINESS WIRE)--In observance of National Patient Safety Awareness Week (March 10-16, 2024), HD Nursing, the leading patient safety solution…
MINNEAPOLIS, March 7, 2024 /PRNewswire/ -- People who have headaches after experiencing concussions may also be more likely to have…
MALVERN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing,…
On-track to report topline Phase 3 data from the KOASTAL-1 study with navacaprant in MDD in the second half of…